Our CEO Immanuel Lerner will be attending & presenting at the NextGen Biomed 2025 in London, March 12-13
Join our CEO, Immanuel Lerner for insights on AI-driven peptide drug discovery:📅 March 12:🗝 Keynote – Orally Available Peptides | 9:55 AM💡 Panel – Novel Peptide Therapeutics | 12:30 PM 📅 March 13:🎙 Moderator – Optimizing Drug Candidates | 2:15 PM